Brown CH. Febrile neutropenia infections. US Pharm. 2013;38(5)(Suppl Oncology Suppl):3-7. http://www.uspharmacist.com/content/s/249/c/40719/. Accessed 05 Sep 2013
Freifeld AG, Bow EJ, Sepkowitz KA, et al; Infectious Diseases Society of America. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011 Feb;52(4):e56-e93. http://www.ncbi.nlm.nih.gov/pubmed/21258094. PMID: 21258094
Infectious Diseases Society of Taiwan, Hematology Society of Taiwan, Medical Foundation in Memory of Dr. Deh-Lin Cheng, Foundation of Professor Wei-Chuan Hsien for the Infectious Diseases Research and Education, CY Lee’s Research Foundation for Pediatric. Guidelines for the use of antimicrobial agents in patients with febrile neutropenia in Taiwan. J Microbiol Immunol Infect. 2005 Dec;38(6):455-457. PMID: 16341349
Ahmed NM. Management of fever in children with non- chemotherapy-induced neutropenia. UpToDate. https://www.uptodate.com/. Sep 2010. Accessed 14 Feb 2011.
Robbins GK. Fever in the neutropenic adult patient with cancer. UpToDate. https://www.uptodate.com/. Sep 2010. Accessed 14 Feb 2011.
Bertuch AA. Fever in children with chemotherapy-induced neutropenia. UpToDate. https://www.uptodate.com. Sep 2010. Accessed 14 Feb 2011.
Klastersky J, de Naurois J, Rolston K, et al. Management of febrile neutropaenia: European Society for Medical Oncology (ESMO) clinical practice guidelines. Ann Oncol. 2016 Sep;27(Suppl 5):v111-v118. doi: 10.1093/annonc/mdw325. PMID: 27664247
Averbuch D, Orasch C, Cordonnier C, et al; ECIL4, a joint venture of EBMT, EORTC, ICHS, ESGICH/ESCMID and ELN. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. Haematologica. 2013 Dec;98(12):1826-1835. doi: 10.3324/haematol.2013.091025. PMID: 24323983
Bow E. Treatment and prevention of neutropenic fever syndromes in adult cancer patients at low risk for complications. UpToDate. https://www.uptodate.com/. Jan 2020. Accessed 19 Feb 2020.
Carmona-Bayonas A, Jimenez-Fonseca P, de Castro EM, et al. SEOM clinical practice guideline: management and prevention of febrile neutropenia in adults with solid tumors (2018). Clin Transl Oncol. 2019 Jan;21(1):75-86. doi: 10.1007/s12094-018-1983-4. PMID: 30470991
Smith TJ, Bohlke K, Lyman GH, et al; American Society of Clinical Oncology. Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline update. J Clin Oncol. 2015 Oct;33(28):3199-3212. doi: 10.1200/JCO.2015.62.3488. PMID: 26169616
Taplitz RA, Kennedy EB, Bow EJ, et al. Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression: ASCO and IDSA Clinical Practice Guideline update. J Clin Oncol. 2018 Oct;36(30):3043-3054. doi: 10.1200/JCO.18.00374. Accessed 26 Jul 2019. PMID: 30179565
Taplitz RA, Kennedy EB, Bow EJ, et al. Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline update. J Clin Oncol. 2018 May;36(14):1443-1453. doi: 10.1200/JCO.2017.77.6211. PMID: 29461916
Wingard JR. Prophylaxis of infection during chemotherapy-induced neutropenia in high-risk adults. UpToDate. https://www.uptodate.com/. Jan 2020.
Melgar M, Reljic T, Barahona G, et al. Guidance statement for the management of febrile neutropenia in pediatric patients receiving cancer-directed therapy in Central America and the Caribbean. JCO Glob Oncol. 2020 Mar;6:508-517. doi: 10.1200/JGO.19.00329. PMID: 32216650
National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: Hematopoietic growth factors. Version 1.2022. NCCN. https://www.nccn.org/. Dec 2021.
National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: Management of immunotherapy-related toxicities. Version 1.2022. NCCN. https://www.nccn.org/. Feb 2022.
Punnapuzha S, Edemobi PK, Elmoheen A. Febrile neutropenia. Stat Pearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jun.
National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: Hematopoietic growth factors. Version 1.2023. NCCN. https://www.nccn.org/. Dec 2022.
National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: Prevention and treatment of cancer-related infections. Version 3.2022. NCCN. https://www.nccn.org/. Oct 2022.
Keck JM, Wingler MJB, Cretella DA, et al. Approach to fever in patients with neutropenia: a review of diagnosis and management. Ther Adv Infect Dis. 2022 Nov;9:20499361221138346. doi: 10.1177/20499361221138346. PMID: 36451936
Larson RA. Use of granulocyte colony stimulating factors in adult patients with chemotherapy-induced neutropenia and conditions other than acute leukemia, myelodysplastic syndrome, and hematopoietic cell transplantation. UpToDate. https://www.uptodate.com/. 28 Sep 2022.
National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology: hematopoietic growth factors. Version 1.2024. NCCN. https://www.nccn.org/. 19 Oct 2023.
National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology: prevention and treatment of cancer-related infections. Version 1.2023. NCCN. https://www.nccn.org/. 28 Jun 2023.
South Australia (SA) Health. Febrile neutropenia management (adults) clinical guideline. Version 2.0. SA Health. https://www.sahealth.sa.gov.au/. 18 Oct 2023.
Wingard JR. Diagnostic approach to the adult cancer patients with neutropenic fever. UpToDate. https://www.uptodate.com/. 12 Sep 2022.
Wingard JR. Overview of neutropenic fever syndromes. UpToDate. https://www.uptodate.com/. 04 May 2022.
Wingard JR. Risk assessment of adults with chemotherapy-induced neutropenia. UpToDate. https://www.uptodate.com/. 19 Feb 2022.
Wingard JR. Treatment and prevention of neutropenic fever syndromes in adult cancer patients at low risk for complications. UpToDate. https://www.uptodate.com/. 21 Feb 2022.
Wingard JR. Treatment of neutropenic fever syndromes in adults with hematologic malignancies and hematopoietic cell transplant recipients (high-risk patients). UpToDate. https://www.uptodate.com/. 03 May 2023.
Zimmer AJ, Freifeld AG. Optimal management of neutropenic fever in patients with cancer. J Oncol Pract. 2019 Jan;15(1):19-24. doi: 10.1200/JOP.18.00269. PMID: 30629902
National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology: hematopoietic growth factors. Version 2.2024. NCCN. https://www.nccn.org/. 12 Dec 2023.
National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology: prevention and treatment of cancer-related infections. Version 2.2023. NCCN. https://www.nccn.org/. 05 Dec 2023.
